首页|期刊导航|感染、炎症、修复|淋巴细胞与血小板乘积对食管胃静脉曲张内镜治疗后再出血风险的评估价值

淋巴细胞与血小板乘积对食管胃静脉曲张内镜治疗后再出血风险的评估价值OA

Value of the lymphocyte-to-platelet product in assessing the risk of rebleeding after endoscopic treatment of gastroesophageal varices

中文摘要英文摘要

目的 探讨淋巴细胞(LYM)与血小板(PLT)乘积(LYM×PLT)对食管胃静脉曲张(GOV)内镜治疗后再出血风险的评估价值.方法 回顾性选取2023年1月至2025年1月于河南省漯河市中医院接受内镜治疗的GOV患者117例,根据术后再出血情况分为出血组(36例)和未出血组(81例).比较两组基线资料、术前肝功能、免疫凝血指标及门静脉主干内径;采用多因素Logistic回归分析GOV患者内镜治疗后再出血风险的影响因素;采用受试者操作特征(ROC)曲线分析LYM×PLT对GOV患者内镜治疗后再出血风险的预测价值.结果 出血组曲张静脉分级重度比例高于未出血组,差异有统计学意义(P<0.05).出血组白蛋白、LYM、PLT、LYM×PLT低于未出血组,总胆红素、国际标准化比值、Child-Pugh分级C级、门静脉主干内径高于未出血组(P<0.05).多因素Logistic回归分析显示,LYM×PLT降低、Child-Pugh C级、门静脉主干内径增宽是GOV患者内镜治疗后再出血风险的独立危险因素(OR=0.964,95%CI:0.939~0.989,P=0.005;OR=3.228,95%CI:1.454~7.169,P=0.004;OR=1.298,95%CI:1.008~1.672,P=0.044).ROC曲线分析显示,LYM×PLT预测GOV患者内镜治疗后再出血风险的曲线下面积为0.884,截断值为149.51×1018/L2,约登指数为0.679,敏感度、特异度分别为88.89%、79.01%.结论 LYM×PLT降低是GOV内镜治疗后再出血的独立危险因素,且预测价值良好,可为术后高危患者识别、优化管理策略提供参考.

Objective To explore the value of the product of lymphocyte(LYM)and platelet(PLT),designated as LYM×PLT,in assessing the risk of rebleeding after endoscopic treatment of gastroesophageal varices(GOV).Methods A retrospective analysis was conducted on 117 patients with GOV who underwent endoscopic treatment at Luohe Hospital of Traditional Chinese Medicine in Henan Province from January 2023 to January 2025.According to postoperative rebleeding status,patients were divided into a rebleeding group(36 cases)and a non-rebleeding group(81 cases).Baseline data,preoperative liver function,immunological and coagulation indicators,and internal diameter of the main portal vein were compared between the two groups.Multivariate logistic regression analysis was used to identify factors influencing the risk of rebleeding after endoscopic treatment in patients with GOV.Receiver operating characteristic(ROC)curve analysis was performed to evaluate the predictive value of LYM×PLT for rebleeding risk after endoscopic treatment in GOV patients.Results The proportion of patients with severe variceal grade in the rebleeding group was significantly higher than that in the non-rebleeding group(P<0.05).Levels of albumin,LYM,PLT,and LYM×PLT in the rebleeding group were lower than those in the non-rebleeding group,while total bilirubin,international normalized ratio,proportion of Child-Pugh class C,and internal diameter of the main portal vein were higher than those in the non-rebleeding group(P<0.05).Multivariate logistic regression analysis showed that decreased LYM×PLT,Child-Pugh class C,and increased internal diameter of the main portal vein were independent risk factors for rebleeding after endoscopic treatment in patients with GOV(OR=0.964,95%CI:0.939-0.989,P=0.005;OR=3.228,95%CI:1.454-7.169,P=0.004;OR=1.298,95%CI:1.008-1.672,P=0.044).ROC curve analysis demonstrated that the area under the curve of LYM×PLT for predicting rebleeding risk after endoscopic treatment in GOV patients was 0.884,with a cutoff value of 149.51×109/L2,a Youden index of 0.679,and a sensitivity and specificity were 88.89%and 79.01%,respectively.Conclusions Decreased LYM×PLT is an independent risk factor of rebleeding after endoscopic treatment of GOV and demonstrates good predictive value,providing a reference for identifying high-risk patients and optimizing management strategies.

段锐;杨凯歌;侯曦;申晓稚

漯河市中医院急诊科,河南 漯河 462000漯河市中医院急诊科,河南 漯河 462000漯河市中医院急诊科,河南 漯河 462000漯河市中医院脑病科,河南 漯河 462000

食管胃静脉曲张再出血内镜治疗淋巴细胞与血小板乘积风险评估

gastroesophageal varicesrebleedingendoscopic treatmentlymphocyte-platelet productrisk evaluation

《感染、炎症、修复》 2026 (4)

390-395,6

2022年度河南省中医药科学研究专项课题(2022ZY1194)

10.3969/j.issn.1672-8521.2026.04.010

评论